UCB Biosciences GmbH

ShareShare on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn
Country: Germany
Location: CLC
Core partner
UCB is a global biopharmaceutical company focused to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With 8500 people in 40 countries, the company generated revenue of € 3.3 bn in 2014.
Dr. Barbara Stegmann

Comments are closed.